Accurate targeting of botulinum toxin injections: How to and why

Parkinsonism and Related Disorders

Volumn 17, Issue SUPPL. 1, 2011, Pages

  Lim, Erle C H ^a   Quek, Amy M L ^a   Seet, Raymond C S ^a  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

Accurate; Botulinum toxin; Diffusion; Targeting

Indexed keywords

BOTULINUM TOXIN;

ACCURACY; ARTICLE; CERVICAL DYSTONIA; COMPUTER ASSISTED TOMOGRAPHY; DRUG DIFFUSION; DRUG EFFECT; DRUG MONITORING; DRUG SAFETY; DRUG TARGETING; DRUG USE; DYSPHAGIA; DYSPHONIA; ECHOGRAPHY; ELECTROMYOGRAPHY; ELECTROSTIMULATION; ENDOSCOPY; FLUOROSCOPY; HUMAN; INTERMETHOD COMPARISON; MEDICATION ERROR; MUSCLE ACTION POTENTIAL; MUSCLE CONTRACTION; MUSCLE WEAKNESS; MUSICIAN'S DYSTONIA; PRIORITY JOURNAL; WRITER'S CRAMP;

ANIMALS; BOTULINUM TOXINS; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; HUMANS; INJECTIONS, INTRAMUSCULAR; MOVEMENT DISORDERS; MUSCLE FATIGUE; MUSCLE, SKELETAL;

EID: 80054112007     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.06.016     Document Type: Article

References (54)

1. Lim E.C., Seet R.C. Use of botulinum toxin in the neurology clinic. Nat Rev Neurol 2010, 6:624-636.
2. Pickett A. Dysport: pharmacological properties and factors that influence toxin action. Toxicon 2009, 54:683-689.
3. Aoki K., Smith L.A., Atassi M. Mode of action of botulinum neurotoxins: current vaccination strategies and molecular immune recognition. Crit Rev Immunol 2010, 30:167-187.
4. Jabbari B. Botulinum neurotoxins in the treatment of refractory pain. Nat Clin Pract Neurol 2008, 4:676-685.
5. Mense S. Neurobiological basis for the use of botulinum toxin in pain therapy. J Neurol 2004, 251(Suppl):I1-I7.
6. Lim E.C., Seet R.C. Botulinum toxin: description of injection techniques and examination of controversies surrounding toxin diffusion. Acta Neurol Scand 2008, 117:73-84.
7. Costa J., Espírito-Santo C., Borges A., Ferreira J.J., Coelho M., Moore P., et al. Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev 2005, 1. CD003633.
8. Racette B.A., Lopate G., Good L., Sagitto S., Perlmutter J.S. Ptosis as a remote effect of therapeutic botulinum toxin B injection. Neurology 2002, 59:1445-1447.
9. Ross M.H., Charness M.E., Sudarsky L., Logigian E.L. Treatment of occupational cramp with botulinum toxin: diffusion of toxin to adjacent noninjected muscles. Muscle Nerve 1997, 20:593-598.
10. de Almeida A.T., De Boulle K. Diffusion characteristics of botulinum neurotoxin products and their clinical significance in cosmetic applications. J Cosmet Laser Ther 2007, 9(Suppl):17-22.
11. Comella C.L., Jankovic J., Brin M.F. Use of botulinum toxin type A in the treatment of cervical dystonia. Neurology 2000, 55(12 Suppl. 5):S15-S21.
12. Pickett A., Rosales R.L. New trends in the science of botulinum toxin-A as applied in dystonia. Int J Neurosci 2011, 121(Suppl):22-34.
13. Nelson A.J., Blake D.T., Chen R. Digit-specific aberrations in the primary somatosensory cortex in writer's cramp. Ann Neurol 2009, 66:146-154.
14. Lim A.Y., Pereira B.P., Kumar V.P., De Coninck C., Taki C., Baudet J., et al. Intramuscular innervation of upper-limb skeletal muscles. Muscle Nerve 2004, 29:523-530.
15. Sihler C. Ueber muskelspindeln und intramuskulare nervenendigunden bei schlangen und froschen. Arch Mikros Anat Entwickl 1895, 46:709-723.
16. Bickerton L.E., Agur A.M., Ashby P. Flexor digitorum superficialis: locations of individual muscle bellies for botulinum toxin injections. Muscle Nerve 1997, 20:1041-1043.
17. Sitburana O., Wu L.J., Sheffield J.K., Davidson A., Jankovic J. Motor overflow and mirror dystonia. Parkinsonism Relat Disord 2009, 15:758-761.
18. Kinnett D. Botulinum toxin A injections in children: technique and dosing issues. Am J Phys Med Rehabil 2004, 83(Suppl):S59-S64.
19. Bentsianov B., Blitzer A. Facial anatomy. Clin Dermatol 2004, 22:3-13.
20. Delagi E.F., Perotto A. Anatomic guide for the electromyographer 1980, Charles C. Thomas, Springfield, IL.
21. Bashashati M., Andrews C., Ghosh S., Storr M. Botulinum toxin in the treatment of diffuse esophageal spasm. Dis Esophagus 2010, 23:554-560.
22. Ford C.N., Bless D.M., Lowery J.D. Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia. Otolaryngol Head Neck Surg 1990, 103:752-758.
23. Tsai S.J., Ying T.H., Huang Y.H., Cheng J.W., Bih L.I., Lew H.L. Transperineal injection of botulinum toxin A for treatment of detrusor sphincter dyssynergia: localization with combined fluoroscopic and electromyographic guidance. Arch Phys Med Rehabil 2009, 90:832-836.
24. Glass G.A., Ku S., Ostrem J.L., Heath S., Larson P.S. Fluoroscopic, EMG-guided injection of botulinum toxin into the longus colli for the treatment of anterocollis. Parkinsonism Relat Disord 2009, 15:610-613.
25. Yoon S.J., Ho J., Kang H.Y., Lee S.H., Kim K.I., Shin W.G., et al. Low-dose botulinum toxin type A for the treatment of refractory piriformis syndrome. Pharmacotherapy 2007, 27:657-665.
26. Christo P.J., Christo D.K., Carinci A.J., Freischlag J.A. Single CT-guided chemodenervation of the anterior scalene muscle with botulinum toxin for neurogenic thoracic outlet syndrome. Pain Med 2010, 11:504-511.
27. Brin M.F. Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity. Spasticity study group. Muscle Nerve 1997, 6(Suppl):S208-S220.
28. Moore P., Naumann M. Muscles and recommended dose ranges of botulinum toxins for adults. Handbook of botulinum toxin treatment 2005, 38-53. Blackwell, Cornwall. P. Moore, M. Naumann (Eds.).
29. Dressler D. Electromyographic evaluation of cervical dystonia for planning of botulinum toxin therapy. Eur J Neurol 2000, 7:713-718.
30. Traba López A., Esteban A. Botulinum toxin in motor disorders: practical considerations with emphasis on interventional neurophysiology. Neurophysiol Clin 2001, 31:220-229.
31. Tarsy D., Simon D.K. Dystonia. N Engl J Med 2006, 355:818-829.
32. O'Brien C.F. Injection techniques for botulinum toxin using electromyography and electrical stimulation. Muscle Nerve 1997, 6(Suppl):S176-S180.
33. Smith J., Finnoff J.T. Diagnostic and interventional musculoskeletal ultrasound: part 2. Clinical applications. PM R 2009, 1:162-177.
34. Chuang Y.C., Chancellor M.B. The application of botulinum toxin in the prostate. J Urol 2006, 176:2375-2382.
35. Jongerius P.H., Joosten F., Hoogen F.J., Gabreels F.J., Rotteveel J.J. The treatment of drooling by ultrasound-guided intraglandular injections of botulinum toxin type A into the salivary glands. Laryngoscope 2003, 113:107-111.
36. Depedibi R., Unlü E., Cevikol A., Akkaya T., Cakci A., Cerekçi R., et al. Ultrasound-guided botulinum toxin type A injection to the iliopsoas muscle in the management of children with cerebral palsy. NeuroRehabilitation 2008, 23:199-205.
37. Maria G., Cadeddu F., Brandara F., Marniga G., Brisinda G. Experience with type A botulinum toxin for treatment of outlet-type constipation. Am J Gastroenterol 2006, 101:2570-2575.
38. Alter K.E. High-frequency ultrasound guidance for neurotoxin injections. Phys Med Rehabil Clin N Am 2010, 21:607-630.
39. Henzel M.K., Munin M.C., Niyonkuru C., Skidmore E.R., Weber D.J., Zafonte R.D. Comparison of surface and ultrasound localization to identify forearm flexor muscles for botulinum toxin injections. PM R 2010, 2:642-646.
40. Py A.G., Zein Addeen G., Perrier Y., Carlier R.Y., Picard A. Evaluation of the effectiveness of botulinum toxin injections in the lower limb muscles of children with cerebral palsy. Preliminary prospective study of the advantages of ultrasound guidance. Ann Phys Rehabil Med 2009, 52:215-223.
41. Oddy M.J., Brown C., Mistry R., Eastwood D.M. Botulinum toxin injection site localization for the tibialis posterior muscle. J Pediatr Orthop B 2006, 15:414-417.
42. Schroeder A.S., Berweck S., Lee S.H., Heinen F. Botulinum toxin treatment of children with cerebral palsy-a short review of different injection techniques. Neurotox Res 2006, 9:189-196.
43. Berweck S., Wissel J. Sonographic imaging for guiding botulinum toxin injections in limb muscles. Adv Clin Neurosci Rehabil 2004, 4:28-31.
44. Berweck S., Heinen F. Treatment of cerebral palsy with botulinum toxin A-principles, clinical practice, atlas 2003, 1-142. Bonn: Child & Brain. S. Berweck, F. Heinen (Eds.).
45. Westhoff B., Seller K., Wild A., Jaeger M., Krauspe R. Ultrasound-guided botulinum toxin injection technique for the iliopsoas muscle. Dev Med Child Neurol 2003, 45:829-832.
46. Lake J.M., Wong R.K. Review article: the management of achalasia-a comparison of different treatment modalities. Aliment Pharmacol Ther 2006, 24:909-918.
47. Kalloo A.N., Pasricha P.J. Therapy of sphincter of Oddi dysfunction. Gastrointest Endosc Clin N Am 1996, 6:117-125.
48. Reddymasu S.C., Singh S., Sankula R., Lavenbarg T.A., Olyaee M., McCallum R.W. Endoscopic pyloric injection of botulinum toxin-A for the treatment of postvagotomy gastroparesis. Am J Med Sci 2009, 337:161-164.
49. Gamé X., Castel-Lacanal E., Bentaleb Y., Thiry-Escudié I., De Boissezon X., Malavaud B., et al. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. Eur Urol 2008, 53:613-618.
50. Lim S.K., Quek P.L. Intraprostatic and bladder-neck injection of botulinum A toxin in treatment of males with bladder-neck dyssynergia: a pilot study. Eur Urol 2008, 53:620-625.
51. Chen S.L., Bih L.I., Huang Y.H., Tsai S.J., Lin T.B., Kao Y.L. Effect of single botulinum toxin A injection to the external urethral sphincter for treating detrusor external sphincter dyssynergia in spinal cord injury. J Rehabil Med 2008, 40:744-748.
52. Blitzer A. Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series. Eur J Neurol 2010, 17(Suppl):28-30.
53. García Ruiz P.J., Cenjor Español C., Sanchez Bernardos V., Astarloa R., Sanabria J., García de Yébenes J. Botulinum toxin treatment for spasmodic dysphonia: percutaneous versus transoral approach. Clin Neuropharmacol 1998, 21:196-198.
54. Simpson D.M., Gracies J.M., Graham H.K., Miyasaki J.M., Naumann M., Russman B., et al. Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 2008, 70:1691-1698.